Warfarin - How Good Are we at Maintaining Target Range ?

University of Dundee

Status: Completed

Conditions: Atrial Fibrillation

Study type: Observational

Funder types: Other

Identifiers

NCT01081327

ELD007

Details and patient eligibility

About

Patients with atrial fibrillation are often anticoagulated with Warfarin. Warfarin has a narrow therapeutic window requiring frequent monitoring. This study aims to investigate the incidence of adverse events in the "real world" for patients receiving Warfarin for lone atrial fibrillation.

Enrollment: 5,000 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Prescription for Warfarin
• Atrial Fibrillation

Exclusion criteria

• Other conditions associated with increased risk of embolisation e.g. rheumatic valve disease, atrial mixoma.
• Conditions with increased risk of bleeding.

Trial design

5,000 participants in 1 patient group

Patients receiving Warfarin